Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT

被引：0
|
作者：
Delmas, P. D.
Bauer, D.
Black, D.
Boonen, S. R.
Cosman, F.
Eastell, R.
机构：
[1] Univ Lyon 1, Dept Med, F-69365 Lyon, France
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[4] Univ Louvain, Ctr Metab Bone Dis, Louvain, Belgium
[5] Helen Hayes Hosp, Dept Med, W Haverstraw, NY USA
[6] No Gen Hosp, Metab Bone Ctr, Sheffield S5 7AU, S Yorkshire, England
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: data from HORIZON-PFT
    Delmas, P. D.
    Bauer, D.
    Black, D.
    Boonen, S.
    Cosman, F.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S130 - S131
  • [2] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-pft
    Delmas, P.
    Bauer, D.
    Black, D.
    Boonen, S.
    Cosman, F.
    Eriksen, E. F.
    Mesenbrink, R.
    Eastell, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
  • [3] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
    Delmas, Pierre
    Bauer, Douglas
    Black, Dennis
    Boonen, Steven R.
    Cosman, Felicia
    Eastell, Richard
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S214 - S215
  • [4] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Black, D.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Boonen, S.
    Cauley, J.
    Cosman, F.
    Lakatos, R.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Hue, T.
    Cummings, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 101 - 101
  • [5] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Miller, P.
    Delmas, R.
    Sellmeyer, D.
    Abrams, K.
    Hu, H.
    Lippuner, K.
    Boonen, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 524
  • [6] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: Results from horizon-PFT
    Miller, Paul
    Sellmeyer, Deborah
    Boonen, Steven R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S227 - S228
  • [7] Renal safety of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis: results from HORIZON-PFT
    Miller, P.
    Sellmeyer, D.
    Boonen, S.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S129 - S130
  • [8] Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with Osteoporosis: Results from HORIZON-PFT.
    Black, D.
    Delmas, P.
    Eastell, R.
    Reid, I.
    Boonen, S.
    Cauley, J.
    Cosman, F.
    Lakatos, P.
    Leung, P. C.
    Man, Z.
    Eriksen, E. F.
    Mesenbrink, P.
    Hue, T.
    Cummings, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S174 - S175
  • [9] ONCE-YEARLY ZOLEDRONIC ACID 5 MG INFUSION FOR TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: EFFECTS ON FRACTURE INCIDENCE IN PATIENT SUBGROUPS FROM THE HORIZON-PFT STUDY
    Eastell, Richard
    Black, Dennis M.
    Boonen, Steven
    McLellan, Alastair R.
    Cummings, Steven R.
    Delmas, Pierre D.
    Palermo, Lisa
    Mesenbrink, Peter
    Cauley, Jane A.
    RHEUMATOLOGY, 2009, 48 : I105 - I105
  • [10] Effect of Once-Yearly Zoledronic Acid 5 mg Infusion on Fracture Incidence in Postmenopausal Osteoporosis: Subgroup Analysis of the Horizon PFT Study
    Eastell, R.
    Black, D. M.
    Boonen, S.
    Cummings, S. R.
    Delmas, P. D.
    Palermo, L.
    Mesenbrink, P.
    Cauley, J. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S9 - S9
12345